A detailed history of Range Financial Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Range Financial Group LLC holds 5,700 shares of BMY stock, worth $333,450. This represents 0.41% of its overall portfolio holdings.

Number of Shares
5,700
Holding current value
$333,450
% of portfolio
0.41%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$39.66 - $51.75 $226,061 - $294,975
5,700 New
5,700 $294,000
Q1 2024

Apr 12, 2024

BUY
$47.98 - $54.4 $271,134 - $307,414
5,651 Added 19.29%
34,942 $1.89 Million
Q4 2023

Jan 10, 2024

BUY
$48.48 - $57.85 $31,269 - $37,313
645 Added 2.25%
29,291 $1.5 Million
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $13,546 - $15,146
234 Added 0.82%
28,646 $1.66 Million
Q2 2023

Jul 18, 2023

BUY
$63.71 - $70.74 $1.01 Million - $1.12 Million
15,775 Added 124.83%
28,412 $1.82 Million
Q1 2023

Apr 03, 2023

SELL
$65.71 - $74.53 $28,518 - $32,346
-434 Reduced 3.32%
12,637 $875,000
Q4 2022

Jan 13, 2023

BUY
$68.48 - $81.09 $4,588 - $5,433
67 Added 0.52%
13,071 $0
Q3 2022

Oct 13, 2022

BUY
$0.13 - $76.84 $11 - $6,992
91 Added 0.7%
13,004 $924,000
Q2 2022

Jul 11, 2022

SELL
$72.62 - $79.98 $61,799 - $68,062
-851 Reduced 6.18%
12,913 $994,000
Q1 2022

May 18, 2022

BUY
$61.48 - $73.72 $46,110 - $55,290
750 Added 5.76%
13,764 $1.01 Million
Q4 2021

Jul 11, 2022

BUY
$53.63 - $62.52 $28,263 - $32,948
527 Added 4.22%
13,014 $811,000
Q3 2021

Jul 11, 2022

BUY
$59.17 - $69.31 $19,585 - $22,941
331 Added 2.72%
12,487 $739,000
Q2 2021

Jul 11, 2022

BUY
$61.91 - $67.42 $131,496 - $143,200
2,124 Added 21.17%
12,156 $812,000
Q1 2021

Jul 11, 2022

BUY
$59.34 - $66.74 $595,298 - $669,535
10,032 New
10,032 $633,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Range Financial Group LLC Portfolio

Follow Range Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Range Financial Group LLC with notifications on news.